Dynein cleavage and microtubule accumulation in okadaic acid-treated neurons

Neuroscience Letters

Volumn 437, Issue 2, 2008, Pages 111-115

  Yoon, Seung Yong ^a,b   Choi, Jung Eun ^a   Choi, Jin Myung ^a   Kim, Dong Hou ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b National Institute of Scientific Investigation   (South Korea)

Author keywords

Calpain; Dynein intermediate chain; p150Glued dynactin

Indexed keywords

CALPAIN; DYNACTIN; DYNEIN ADENOSINE TRIPHOSPHATASE; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE 2A INHBITOR; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; TUBULIN;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL CULTURE; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLATION; ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM HYDROXIDE; CELLS, CULTURED; CEREBRAL CORTEX; DRUG COMBINATIONS; DYNEIN ATPASE; ENZYME INHIBITORS; MICROTUBULES; NEURONS; OKADAIC ACID; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; TUBULIN; TYROSINE;

EID: 42749083780     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.03.083     Document Type: Article

References (23)

1. Ahmad F.J., Echeverri C.J., Vallee R.B., and Baas P.W. Cytoplasmic dynein and dynactin are required for the transport of microtubules into the axon. J. Cell Biol. 140 (1998) 391-401
2. Arriagada P.V., Growdon J.H., Hedley-Whyte E.T., and Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42 (1992) 631-639
3. Bulinski J.C., and Gundersen G.G. Stabilization of posttranslational modification of microtubules during cellular morphogenesis. Bioessays 13 (1991) 285-293
4. Favre B., Turowski P., and Hemmings B.A. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J. Biol. Chem. 272 (1997) 13856-13863
5. Gong C.X., Lidsky T., Wegiel J., Zuck L., Grundke-Iqbal I., and Iqbal K. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J. Biol. Chem. 275 (2000) 5535-5544
6. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., and Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 4913-4917
7. Hong H.N., Yoon S.Y., Suh J., Lee J.H., and Kim D. Differential activation of caspase-3 at two maturational stages during okadaic acid-induced rat neuronal death. Neurosci. Lett. 334 (2002) 63-67
8. Kim D., Su J., and Cotman C.W. Sequence of neurodegeneration and accumulation of phosphorylated tau in cultured neurons after okadaic acid treatment. Brain Res. 839 (1999) 253-262
9. Kopec K., and Chambers J.P. Effect of Alzheimer's brain extracts on dynein immunoreactivity in PC12 cells. Proc. Soc. Exp. Biol. Med. 216 (1997) 429-437
10. Lane J.D., Vergnolle M.A., Woodman P.G., and Allan V.J. Apoptotic cleavage of cytoplasmic dynein intermediate chain and p150(Glued) stops dynein-dependent membrane motility. J. Cell Biol. 153 (2001) 1415-1426
11. Lim S.S., Sammak P.J., and Borisy G.G. Progressive and spatially differentiated stability of microtubules in developing neuronal cells. J. Cell Biol. 109 (1989) 253-263
12. Liu Z., Steward R., and Luo L. Drosophila Lis1 is required for neuroblast eration, dendritic elaboration and axonal transport. Nat. Cell Biol. 2 (2000) 776-783
13. Merrick S.E., Trojanowski J.Q., and Lee V.M. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J. Neurosci. 17 (1997) 5726-5737
14. Runnegar M.T., Wei X., and Hamm-Alvarez S.F. Increased protein phosphorylation of cytoplasmic dynein results in impaired motor function. Biochem. J. 342 Pt 1 (1999) 1-6
15. Sasahara Y., Kobayashi T., Onodera H., Onoda M., Ohnishi M., Kato S., Kusuda K., Shima H., Nagao M., Abe H., Yanagawa Y., Hiraga A., and Tamura S. Okadaic acid suppresses neural differentiation-dependent expression of the neurofilament-l gene in P19 embryonal carcinoma cells by post-transcriptional modification. J. Biol. Chem. 271 (1996) 25950-25957
16. Sontag E., Hladik C., Montgomery L., Luangpirom A., Mudrak I., Ogris E., and White III C.L. Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J. Neuropathol. Exp. Neurol. 63 (2004) 1080-1091
17. Sun L., Liu S.Y., Zhou X.W., Wang X.C., Liu R., Wang Q., and Wang J.Z. Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience 118 (2003) 1175-1182
18. Trojanowski J.Q., and Lee V.M. The role of tau in Alzheimer's disease. Med. Clin. North Am. 86 (2002) 615-627
19. Vallee R.B., and Bloom G.S. Mechanisms of fast and slow axonal transport. Annu. Rev. Neurosci. 14 (1991) 59-92
20. Vaughan K.T., and Vallee R.B. Cytoplasmic dynein binds dynactin through a direct interaction between the intermediate chains and p150Glued. J. Cell Biol. 131 (1995) 1507-1516
21. Vaughan P.S., Leszyk J.D., and Vaughan K.T. Cytoplasmic dynein intermediate chain phosphorylation regulates binding to dynactin. J. Biol. Chem. 276 (2001) 26171-26179
22. Yoon S., Choi J., Huh J.W., Hwang O., and Kim D. Calpain activation in okadaic-acid-induced neurodegeneration. Neuroreport 17 (2006) 689-692
23. Yoon S.Y., Choi J.E., Huh J.W., Hwang O., Lee H.S., Hong H.N., and Kim D. Monastrol a selective inhibitor of the mitotic kinesin Eg5, induces a distinctive growth profile of dendrites and axons in primary cortical neuron cultures. Cell Motil. Cytoskeleton 60 (2005) 181-190